No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
作者信息
Wegner Dennis L
出版信息
MLO Med Lab Obs. 2005 Jan;37(1):26-9.
PMID:15743145
Abstract
摘要
相似文献
1
No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
MLO Med Lab Obs. 2005 Jan;37(1):26-9.
2
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Clin Infect Dis. 2002 Jun 1;34(11):1481-90. doi: 10.1086/340353. Epub 2002 May 13.
3
Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
J Antimicrob Chemother. 2008 Aug;62(2):381-3. doi: 10.1093/jac/dkn180. Epub 2008 Apr 28.
4
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Clin Ther. 2007 Apr;29(4):759-60; author reply 760-1.
5
Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
Clin Infect Dis. 2002 Oct 15;35(8):1018-20. doi: 10.1086/342698. Epub 2002 Sep 26.
6
Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Scand J Infect Dis. 2005;37(11-12):946-9. doi: 10.1080/00365540500263110.
7
Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Int J Antimicrob Agents. 2005 Dec;26(6):442-8. doi: 10.1016/j.ijantimicag.2005.09.003. Epub 2005 Nov 10.
8
Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Ann Pharmacother. 2007 Feb;41(2):235-44. doi: 10.1345/aph.1H414. Epub 2007 Feb 13.
9
Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
Spine (Phila Pa 1976). 2006 Oct 15;31(22):E830-2. doi: 10.1097/01.brs.0000241065.19723.13.
10
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Antimicrob Agents Chemother. 2007 Sep;51(9):3397-400. doi: 10.1128/AAC.01242-06. Epub 2007 Jun 25.
Zotero 插件